Literature DB >> 7638205

Multimeric complexes of the PML-retinoic acid receptor alpha fusion protein in acute promyelocytic leukemia cells and interference with retinoid and peroxisome-proliferator signaling pathways.

J H Jansen1, A Mahfoudi, S Rambaud, C Lavau, W Wahli, A Dejean.   

Abstract

The t(15;17) chromosomal translocation, specific for acute promyelocytic leukemia (APL), fuses the PML gene to the retinoic acid receptor alpha (RAR alpha) gene, resulting in expression of a PML-RAR alpha hybrid protein. In this report, we analyzed the nature of PML-RAR alpha-containing complexes in nuclear protein extracts of t(15;17)-positive cells. We show that endogenous PML-RAR alpha can bind to DNA as a homodimer, in contrast to RAR alpha that requires the retinoid X receptor (RXR) dimerization partner. In addition, these cells contain oligomeric complexes of PML-RAR alpha and endogenous RXR. Treatment with retinoic acid results in a decrease of PML-RAR alpha protein levels and, as a consequence, of DNA binding by the different complexes. Using responsive elements from various hormone signaling pathways, we show that PML-RAR alpha homodimers have altered DNA-binding characteristics when compared to RAR alpha-RXR alpha heterodimers. In transfected Drosophila SL-3 cells that are devoid of endogenous retinoid receptors PML-RAR alpha inhibits transactivation by RAR alpha-RXR alpha heterodimers in a dominant fashion. In addition, we show that both normal retinoid receptors and the PML-RAR alpha hybrid bind and activate the peroxisome proliferator-activated receptor responsive element from the Acyl-CoA oxidase gene, indicating that retinoids and peroxisome proliferator receptors may share common target genes. These properties of PML-RAR alpha may contribute to the transformed phenotype of APL cells.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7638205      PMCID: PMC41347          DOI: 10.1073/pnas.92.16.7401

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  21 in total

1.  An estrogen-responsive element derived from the 5' flanking region of the Xenopus vitellogenin A2 gene functions in transfected human cells.

Authors:  L Klein-Hitpass; M Schorpp; U Wagner; G U Ryffel
Journal:  Cell       Date:  1986-09-26       Impact factor: 41.582

2.  The thyroid hormone receptor binds with opposite transcriptional effects to a common sequence motif in thyroid hormone and estrogen response elements.

Authors:  C K Glass; J M Holloway; O V Devary; M G Rosenfeld
Journal:  Cell       Date:  1988-07-29       Impact factor: 41.582

3.  Identification of a retinoic acid responsive element in the retinoic acid receptor beta gene.

Authors:  H de Thé; M M Vivanco-Ruiz; P Tiollais; H Stunnenberg; A Dejean
Journal:  Nature       Date:  1990-01-11       Impact factor: 49.962

4.  Retinoic acid regulates aberrant nuclear localization of PML-RAR alpha in acute promyelocytic leukemia cells.

Authors:  K Weis; S Rambaud; C Lavau; J Jansen; T Carvalho; M Carmo-Fonseca; A Lamond; A Dejean
Journal:  Cell       Date:  1994-01-28       Impact factor: 41.582

5.  Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei.

Authors:  J D Dignam; R M Lebovitz; R G Roeder
Journal:  Nucleic Acids Res       Date:  1983-03-11       Impact factor: 16.971

6.  A direct repeat in the cellular retinol-binding protein type II gene confers differential regulation by RXR and RAR.

Authors:  D J Mangelsdorf; K Umesono; S A Kliewer; U Borgmeyer; E S Ong; R M Evans
Journal:  Cell       Date:  1991-08-09       Impact factor: 41.582

7.  The PML-RAR alpha fusion mRNA generated by the t(15;17) translocation in acute promyelocytic leukemia encodes a functionally altered RAR.

Authors:  H de Thé; C Lavau; A Marchio; C Chomienne; L Degos; A Dejean
Journal:  Cell       Date:  1991-08-23       Impact factor: 41.582

8.  Chromosomal translocation t(15;17) in human acute promyelocytic leukemia fuses RAR alpha with a novel putative transcription factor, PML.

Authors:  A Kakizuka; W H Miller; K Umesono; R P Warrell; S R Frankel; V V Murty; E Dmitrovsky; R M Evans
Journal:  Cell       Date:  1991-08-23       Impact factor: 41.582

9.  Structure and sequence of the promoter area and of a 5' upstream demethylation site of the estrogen-regulated chicken vitellogenin ii gene.

Authors:  M Geiser; I W Mattaj; A F Wilks; M Seldran; J P Jost
Journal:  J Biol Chem       Date:  1983-07-25       Impact factor: 5.157

10.  The t(15;17) translocation alters a nuclear body in a retinoic acid-reversible fashion.

Authors:  M H Koken; F Puvion-Dutilleul; M C Guillemin; A Viron; G Linares-Cruz; N Stuurman; L de Jong; C Szostecki; F Calvo; C Chomienne
Journal:  EMBO J       Date:  1994-03-01       Impact factor: 11.598

View more
  11 in total

1.  MLL-AFX requires the transcriptional effector domains of AFX to transform myeloid progenitors and transdominantly interfere with forkhead protein function.

Authors:  Chi Wai So; Michael L Cleary
Journal:  Mol Cell Biol       Date:  2002-09       Impact factor: 4.272

2.  SMRT corepressor interacts with PLZF and with the PML-retinoic acid receptor alpha (RARalpha) and PLZF-RARalpha oncoproteins associated with acute promyelocytic leukemia.

Authors:  S H Hong; G David; C W Wong; A Dejean; M L Privalsky
Journal:  Proc Natl Acad Sci U S A       Date:  1997-08-19       Impact factor: 11.205

3.  Dimerization-induced corepressor binding and relaxed DNA-binding specificity are critical for PML/RARA-induced immortalization.

Authors:  Jun Zhou; Laurent Pérès; Nicole Honoré; Rihab Nasr; Jun Zhu; Hugues de Thé
Journal:  Proc Natl Acad Sci U S A       Date:  2006-06-06       Impact factor: 11.205

4.  NPM and BRG1 Mediate Transcriptional Resistance to Retinoic Acid in Acute Promyelocytic Leukemia.

Authors:  Jessica N Nichol; Matthew D Galbraith; Claudia L Kleinman; Joaquín M Espinosa; Wilson H Miller
Journal:  Cell Rep       Date:  2016-03-17       Impact factor: 9.423

5.  Comprehensive genomic screens identify a role for PLZF-RARalpha as a positive regulator of cell proliferation via direct regulation of c-MYC.

Authors:  Kim L Rice; Itsaso Hormaeche; Sergei Doulatov; Jared M Flatow; David Grimwade; Ken I Mills; Magdalena Leiva; Julien Ablain; Charuta Ambardekar; Melanie J McConnell; John E Dick; Jonathan D Licht
Journal:  Blood       Date:  2009-10-23       Impact factor: 22.113

Review 6.  Genome-wide functions of PML-RARα in acute promyelocytic leukaemia.

Authors:  S Saeed; C Logie; H G Stunnenberg; J H A Martens
Journal:  Br J Cancer       Date:  2011-01-18       Impact factor: 7.640

7.  Role of peroxisome proliferator-activated receptor gamma and its ligands in the treatment of hematological malignancies.

Authors:  Tatiana M Garcia-Bates; Geniece M Lehmann; Patricia J Simpson-Haidaris; Steven H Bernstein; Patricia J Sime; Richard P Phipps
Journal:  PPAR Res       Date:  2008       Impact factor: 4.964

8.  The DNA binding property of PML/RARA but not the integrity of PML nuclear bodies is indispensable for leukemic transformation.

Authors:  Xi Liu; Hao Yuan; Laurent Peres; Saijuan Chen; Zhu Chen; Hugues de The; Jun Zhou; Jun Zhu
Journal:  PLoS One       Date:  2014-08-13       Impact factor: 3.240

9.  Pml nuclear body disruption cooperates in APL pathogenesis and impairs DNA damage repair pathways in mice.

Authors:  Edwige Voisset; Eva Moravcsik; Eva W Stratford; Amie Jaye; Christopher J Palgrave; Robert K Hills; Paolo Salomoni; Scott C Kogan; Ellen Solomon; David Grimwade
Journal:  Blood       Date:  2017-11-30       Impact factor: 22.113

10.  PML-RARA-RXR oligomers mediate retinoid and rexinoid/cAMP cross-talk in acute promyelocytic leukemia cell differentiation.

Authors:  Dmitrii Kamashev; Dominique Vitoux; Hugues De Thé
Journal:  J Exp Med       Date:  2004-04-19       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.